EGFR and colorectal carcinoma: Whereas, reduced levels of miR-7, a direct regulator of EGFR, was suggested as a prognostic biomarker and a candidate for targeted therapy in patients with CRC whose tumors were resistant to targeted anti-EGFR therapy [58].